| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.004 |